Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Cohan

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
JAMA|May 12, 2005
Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohortDavid R Berk, Meira S Falkovitz-Halpern, David W Hill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapyCatherine A Koss, Paul Natureeba, Albert Plenty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2017
Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral TherapyChloe R McDonald, Andrea L Conroy, Joel L Gamble, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2013
Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingMonica Gandhi, Julia Mwesigwa, Francesca Aweeka, et al.
American Journal of Obstetrics and Gynecology|September 20, 2016
Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative womenLisa B Haddad, Kristin M Wall, C Christina Mehta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2014
Pregnancy intentions among women living with HIV in the United StatesLisa Rahangdale, Amanda Stewart, Robert D Stewart, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2015
Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan WomenCatherine A Koss, Paul Natureeba, Dorcas Nyafwono, et al.
AIDS (London, England)|November 27, 2014
Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan womenDeborah Cohan, Paul Natureeba, Catherine A Koss, et al.
AIDS (London, England)|May 19, 2015
Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan womenCatherine A Koss, Paul Natureeba, Julia Mwesigwa, et al.
American Journal of Obstetrics and Gynecology|May 29, 2019
Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017Kristin M Wall, Lisa B Haddad, C Christina Mehta, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
JAMA|May 12, 2005
Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohortDavid R Berk, Meira S Falkovitz-Halpern, David W Hill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapyCatherine A Koss, Paul Natureeba, Albert Plenty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2017
Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral TherapyChloe R McDonald, Andrea L Conroy, Joel L Gamble, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2013
Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingMonica Gandhi, Julia Mwesigwa, Francesca Aweeka, et al.
American Journal of Obstetrics and Gynecology|September 20, 2016
Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative womenLisa B Haddad, Kristin M Wall, C Christina Mehta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2014
Pregnancy intentions among women living with HIV in the United StatesLisa Rahangdale, Amanda Stewart, Robert D Stewart, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2015
Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan WomenCatherine A Koss, Paul Natureeba, Dorcas Nyafwono, et al.
AIDS (London, England)|November 27, 2014
Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan womenDeborah Cohan, Paul Natureeba, Catherine A Koss, et al.
AIDS (London, England)|May 19, 2015
Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan womenCatherine A Koss, Paul Natureeba, Julia Mwesigwa, et al.
American Journal of Obstetrics and Gynecology|May 29, 2019
Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017Kristin M Wall, Lisa B Haddad, C Christina Mehta, et al.
Pageof 8